Kennedy Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Kennedy Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-476,912	Closed	-$1.45M	–	755
2015 Q2	$1.45M	Buy	+476,912	New	+$1.34M	0.03%	638
2015 Q1	–	Sell	-51,081	Closed	-$227K	–	761
2014 Q4	$227K	Buy	+51,081	New	+$244K	﹤0.01%	729

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Kennedy Capital Management's ENZ Position: Q3 2015 in Review

Kennedy Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q3 2015, closing a stake of 476,912 shares — an estimated $1.45M sold.

Kennedy Capital Management first reported a position in ENZ in Q4 2014 and held it in 2 quarters. The position peaked at $1.45M in Q2 2015. 82 funds tracked by Wall St. Rank hold ENZ as of Q3 2015.

Kennedy Capital Management reported no remaining Enzo Biochem, Inc. position as of Q3 2015 after selling out during the quarter.
Kennedy Capital Management sold 476,912 Enzo Biochem, Inc. shares in Q3 2015, an estimated $1.45M.
Kennedy Capital Management first reported a position in Enzo Biochem, Inc. in Q4 2014 and held it in 2 quarters.
Kennedy Capital Management's Enzo Biochem, Inc. position peaked at $1.45M in Q2 2015.
82 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2015.

Based on Kennedy Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.